Creative Medical Technology Holdings, Inc. (CELZ)
(Delayed Data from NSDQ)
$3.26 USD
-0.08 (-2.40%)
Updated Aug 2, 2024 03:12 PM ET
After-Market: $3.34 +0.08 (2.45%) 6:54 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Creative Medical Technology Holdings, Inc. [CELZ]
Reports for Purchase
Showing records 41 - 44 ( 44 total )
Company: Creative Medical Technology Holdings, Inc.
Industry: Medical - Biomedical and Genetics
$17M Raised Funds Operations Into 2H24, Latest News Demonstrates Progress
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Creative Medical Technology Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Reasons to Sit Down with These Biotech Managements at the 2022 Conference
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Creative Medical Technology Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Company: Creative Medical Technology Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Leveraging Autologous Adult Stem Cell Therapy Across Multiple Indications -Initiation of Coverage
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J